Eversense® is the only long-term CGM system. It has an advanced sensor that sits comfortably just under the skin of the upper arm and monitors patients’ glucose levels for up to 90 days with demonstrated high accuracy.*1
Provides financial relief to eligible patients with a reduction of out-of-pocket costs. Eligible patients pay the first $100 of their identified out-of-pocket costs, and Ascensia may cover up to $300 of the balance of these costs. The patient is responsible for any remaining balance.†
* For an overview of Eversense CGM safety information, please visit www.eversensediabetes.com/safety-info.
Please visit www.ascensiadiabetes.com/eversense for limitations, restrictions, references and copyright information.
† If a patient does not have insurance and will be paying cash for the product, they may be eligible for the Eversense Patient Assistance Program. Limitations and Restrictions may apply.
‡ Maximum savings limit applies; and will vary depending on patient out of pocket costs. Please see Program Terms, Conditions, and Eligibility Criteria. Limitations and restrictions apply.
Eligible patients with U.S. commercial health insurance may receive up to $300 US dollars towards out-of-pocket costs per Eversense 90 day sensor procedure for up to 1 year from the
date of initial service request. Void where prohibited. Ascensia Diabetes Care reserves the right to terminate the program at any time without notice.
Reference: 1. Christiansen, M. P. et al. (2019). A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: The precision study.
Diabetes Technology & Therapeutics, 21(5), 231-237. doi:10.1089/dia.2019.0020
Please complete your contact details and an Ascensia Diabetes Care representative will follow up with you shortly.
*Field is required